BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today announced it will report second quarter 2014 financial results on Thursday, August 7, 2014. BIND’s management team will host a conference call and audio webcast at 8:30 a.m., Eastern Time on Thursday, August 7, 2014 to discuss the quarterly results and recent business developments.
Help employers find you! Check out all the jobs and post your resume.
